Sustainability & Climate

Daniel Energy Partners appoints Sean Mitchell as CEO and hires veteran analyst Jeff Dietert, doubling down on traditional energy with enhanced research.

National employee-rights firm Barrett & Farahany hires Board Certified Specialist Kathryn Abernethy to lead a major strategic expansion into North Carolina.

The strategic acquisition of Burns Engineering positions DwyerOmega to lead high-stakes industries by combining a broad portfolio with metrology-grade accuracy.

Backed by Pfizer Ventures, Enodia Therapeutics' novel AI platform aims to stop diseases by degrading proteins at their source, a major shift in drug discovery.

Voyager Technologies extends its NASA HUNCH contract, a strategic move to cultivate the next generation of talent for its future Starlab space station.

A key partnership is funding hundreds of activities for military children, providing stability and stress relief during deployment and injury recovery.

The AI-powered marketplace adds advanced materials, CMMC compliance, and new manufacturing controls to meet demands from critical, regulated industries.

With survey fraud costing millions, Rep Data appoints a former Kantar CIO and Research Defender's founder to sharpen its tech and product focus.

A new partnership arms independent cancer clinics with advanced AI and data analytics, aiming to improve patient care and ensure their survival.

A new class of painkillers promises the power of opioids with a far lower risk of addiction. Tris Pharma's cebranopadol could reshape pain management.

NeuroSense adds world-renowned expert Prof. Steven Arnold to its board, a major vote of confidence in its multi-target Alzheimer's drug, PrimeC.

The new venue near EpicCentral isn't just another opening; it's a strategic move in a competitive market, fueling local growth and redefining leisure.

The firm is now recruiting for a Phase 1 trial of HWK-007 and has submitted an IND for HWK-016, targeting tough lung, ovarian, and endometrial cancers.

With multiple clinical trials advancing and a savvy global expansion, RESTEM is poised to challenge the treatment paradigm for autoimmune disorders.

At CES 2026, Hitachi unveiled major AI alliances with NVIDIA and Google, betting its HMAX platform can embed intelligence into the world's core systems.

A new partnership leverages in vivo screening to find novel obesity targets, aiming to revolutionize a market projected to exceed $100 billion.

Cizzle Brands' $83.75M acquisition of Flow Water's manufacturing arm is a strategic masterstroke, creating a vertically integrated beverage powerhouse.

A new national reimbursement code for NeurAxis's IB-Stim therapy is set to revolutionize access for chronic GI pain patients, validating the technology.

After 30 years, CEO Jim Foster will retire, passing the torch to COO Birgit Girshick in a move that signals continuity and a new era of governance.

858 Therapeutics' novel PARG inhibitor offers new hope for patients with a deadly, drug-resistant form of ovarian cancer, accelerating its path to approval.